Skip to main content

Anti-retroviral Therapies

Volume 487: debated on Wednesday 11 February 2009

11. To ask the Secretary of State for International Development what steps his Department is taking to encourage pharmaceutical companies to develop infant formulae for anti-retroviral therapies for use for children in developing countries. (255796)

DFID is supporting a major five year clinical trial implemented by the Medical Research Council (MRC) in Uganda and Zimbabwe, on the best ways to provide antiretroviral drug treatment for infants and children with HIV. Based on this work, new triple formulations for babies and small children were recently approved and are now being distributed to children in Africa. DFID also funds the work of UNITAID and the Clinton Foundation, aimed at developing and facilitating access to new paediatric drug formulations for tuberculosis and HIV.